These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 901096)

  • 1. Hepatorenal syndrome. Recovery after peritoneovenous shunt.
    Pladson TR; Parrish RM
    Arch Intern Med; 1977 Sep; 137(9):1248-9. PubMed ID: 901096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome: reversal by peritoneovenous shunt.
    Fullen WD
    Surgery; 1977 Sep; 82(3):337-41. PubMed ID: 888100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt.
    Wapnick S; Grosberg S; Kinney M; Azzara V; LeVeen HH
    Arch Surg; 1978 May; 113(5):581-5. PubMed ID: 646616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal syndrome managed with hemodialysis, then reversed by peritoneovenous shunting.
    Kearns PJ; Polhemus RJ; Oakes D; Rabkin R
    J Clin Gastroenterol; 1985 Aug; 7(4):341-3. PubMed ID: 4045179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatorenal syndrome.
    Schwartz ML; Vogel SB
    Am J Surg; 1980 Mar; 139(3):370-3. PubMed ID: 7362005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneovenous shunting for ascites.
    Reinhardt GF; Stanley MM
    Surg Gynecol Obstet; 1977 Sep; 145(3):419-24. PubMed ID: 888064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites.
    Witte MH; Witte CL; Jacobs S; Kut R
    JAMA; 1978 Jan; 239(1):31-3. PubMed ID: 579228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatorenal syndrome: recovery after portacaval shunt.
    Ariyan S; Sweeney T; Kerstein MD
    Ann Surg; 1975 Jun; 181(6):847-9. PubMed ID: 1094971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The retroclavicular placement of peritoneovenous shunt tubing.
    Whitehouse WM; Queral LA; Flinn WR; Yao JS; Bergan JJ
    Surgery; 1980 Apr; 87(4):468-9. PubMed ID: 7368091
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
    Violi V; Montanari M; Roncoroni L
    G Chir; 1990; 11(7-8):413-5. PubMed ID: 2282274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function.
    Cade R; Wagemaker H; Vogel S; Mars D; Hood-Lewis D; Privette M; Peterson J; Schlein E; Hawkins R; Raulerson D
    Am J Med; 1987 Mar; 82(3):427-38. PubMed ID: 3548346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal syndrome treated for eight months with continuous-flow peritoneal dialysis.
    Charen E; Dadzie K; Sheth N; Siktel H; Dubrow A; Harbord N; Winchester J; Ronco C; Amerling R
    Adv Perit Dial; 2013; 29():38-42. PubMed ID: 24344489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kidney in Pediatric Liver Disease.
    Matloff RG; Arnon R
    Curr Gastroenterol Rep; 2015 Sep; 17(9):36. PubMed ID: 26289614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneovenous shunt in the management of ascites and the hepatorenal syndrome.
    Epstein M
    Gastroenterology; 1982 Apr; 82(4):790-9. PubMed ID: 7037522
    [No Abstract]   [Full Text] [Related]  

  • 18. The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.
    Kinney MJ; Schneider A; Wapnick S; Grosberg S; LeVeen H
    Nephron; 1979; 23(5):228-32. PubMed ID: 481657
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites.
    Hobar PC; Turner WW; Valentine RJ
    Surgery; 1987 Feb; 101(2):161-4. PubMed ID: 3810487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of patients with malignant ascites for a peritoneovenous shunt.
    Cheung DK; Raaf JH
    Cancer; 1982 Sep; 50(6):1204-9. PubMed ID: 7104966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.